← Back to Search

Other

Battlefield Acupuncture for Hidradenitis Suppurativa

N/A
Recruiting
Research Sponsored by Wayne State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Significant pain from hidradenitis at least twice weekly
Age 18 years or older
Must not have
Disease or disfigurement of the ear that prevents battlefield acupuncture of the ears
Other chronic pain that will interfere with the ability to rate hidradenitis pain
Timeline
Screening 3 weeks
Treatment Varies
Follow Up average score from scores recorded daily for 4 weeks

Summary

This trial will test whether acupuncture can help relieve the pain of hidradenitis suppurativa, a condition that causes red, painful lumps under the skin.

Who is the study for?
This trial is for adults over 18 with a dermatologist-confirmed diagnosis of hidradenitis suppurativa, experiencing significant pain from the condition at least twice weekly. Participants must be on a stable treatment regimen for hidradenitis during the study and have no other chronic pain or ear issues that would interfere with acupuncture.
What is being tested?
The trial is testing battlefield acupuncture against sham (fake) acupuncture to see if it can reduce pain in patients with hidradenitis suppurativa. Battlefield acupuncture involves placing tiny needles in specific points on the ear.
What are the potential side effects?
Potential side effects may include minor bleeding, bruising, or soreness at needle insertion sites on the ear. There's also a small risk of infection and discomfort during the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I experience significant pain from hidradenitis at least twice a week.
Select...
I am 18 years old or older.
Select...
I have been diagnosed with hidradenitis suppurativa by a dermatologist.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot have acupuncture on my ears due to a condition or disfigurement.
Select...
I do not have chronic pain that would affect my ability to assess my hidradenitis pain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~average score from scores recorded daily for 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and average score from scores recorded daily for 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Pain Numerical Rating Score

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: TreatmentExperimental Treatment1 Intervention
2 treatments of battlefield acupuncture to the bilateral ears spaced one week apart
Group II: ControlPlacebo Group1 Intervention
2 treatments with sham acupuncture to the bilateral ears at acupuncture points not associated with pain relief (2 liver and 1 stomach)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Battlefield Acupuncture
2016
Completed Phase 2
~510

Find a Location

Who is running the clinical trial?

Wayne State UniversityLead Sponsor
314 Previous Clinical Trials
110,865 Total Patients Enrolled
1 Trials studying Hidradenitis Suppurativa
30 Patients Enrolled for Hidradenitis Suppurativa

Media Library

Battlefield Acupuncture (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04218422 — N/A
Hidradenitis Suppurativa Research Study Groups: Control, Treatment
Hidradenitis Suppurativa Clinical Trial 2023: Battlefield Acupuncture Highlights & Side Effects. Trial Name: NCT04218422 — N/A
Battlefield Acupuncture (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04218422 — N/A
~18 spots leftby Dec 2030
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top